MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Novo Nordisk

  • Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
    Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
    Learn about the study's possible impact on treatment strategies.
    October 21, 2024BY George Citroner
  • Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
    Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
    Microsoft is in trouble with the EU over its popular collaboration app Teams, and could face a large ...
    June 25, 2024BY Don Ma
  • Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    The company said it conducted tests on compounded drugs that claim to contain semaglutide and found 'concerning levels ...
    December 1, 2023BY Lorenz Duchamps
  • FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
    FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
    The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
    September 26, 2023BY Naveen Athrappully
  • Weight-Loss Jab Wegovy Available for the First Time on NHS
    Weight-Loss Jab Wegovy Available for the First Time on NHS
    A limited supply of the loss jab drug Wegovy has become available to patients via NHS specialists in ...
    September 4, 2023BY Owen Evans
  • Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
    Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
    The European Medicines Agency (EMA) has issued a drug safety signal (pdf) regarding the potential risk of thyroid ...
    June 24, 2023BY Harry Lee
  • Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
    Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
    The federal government is under pressure from the Coalition after removing a key lifesaving drug from the pharmaceutical ...
    March 13, 2023BY Victoria Kelly-Clark
TOP NEWS
  • The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
    NEW By Sheramy Tsai
    The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
  • Senate Panel Advances Bill to Make Hospitals Compete on Price
    1hr By Lawrence Wilson
    Senate Panel Advances Bill to Make Hospitals Compete on Price
  • House Adopts Budget Blueprint for $95 Billion Reconciliation Package
    2hr By Jackson Richman
    House Adopts Budget Blueprint for $95 Billion Reconciliation Package
  • House Passes Congressional Stock Trading Ban
    2hr By Jackson Richman and Nathan Worcester
    House Passes Congressional Stock Trading Ban
  • US Signs Nuclear Cooperation Deal With Saudi Arabia
    2hr By Emel Akan
    US Signs Nuclear Cooperation Deal With Saudi Arabia
  • House Passes Defense Policy Bill That Attaches SAVE America Act
    2hr By Jackson Richman
    House Passes Defense Policy Bill That Attaches SAVE America Act
  • Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
    3hr By Jack Phillips
    Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
  • US, Ukraine Sign Agreement for Drone Testing
    3hr By Jill McLaughlin
    US, Ukraine Sign Agreement for Drone Testing
  • White House Says NJ Noncitizen Voter Error Suggests Need for SAVE America Act
    4hr By Jack Phillips
    White House Says NJ Noncitizen Voter Error Suggests Need for SAVE America Act
  • Doctor Urges Medical Community to Take Action Against China’s Forced Organ Harvesting
    5hr By Frank Fang
    Doctor Urges Medical Community to Take Action Against China’s Forced Organ Harvesting
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top